Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Adipose tissue NK cells manifest an activated phenotype in human obesity.

O'Rourke RW., Gaston GD., Meyer KA., White AE., Marks DL.

Laboratory Study, published in Metabolism (2013) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Metabolism (2013)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
24012153
PMCID
PMC3809342
DOI
10.1016/j.metabol.2013.07.011
Citations
52

Abstract (original English)

Objective Adipose tissue inflammation is a cause of obesity-related metabolic disease. Natural killer (NK) cells are an understudied cell type in the context of obesity. The goal of this study was to determine the phenotype of human adipose tissue NK cells. Methods We used flow cytometry phenotyping to study adipose tissue and peripheral blood NK cells from obese and lean humans. Results Human adipose tissue NK cells, relative to peripheral blood NK cells, express increased levels of activation markers. Adipose tissue NK cells also demonstrate an activated phenotype in obese relative to lean subjects, with increased expression of the activating receptor NKG2D. Conclusions These data are the first detailed phenotypic characterization of human adipose tissue NK cells, and suggest a role for NK cells in adipose tissue inflammation in obesity.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdultBody Mass IndexCD3 ComplexCD56 AntigenCell SeparationFemaleFlow CytometryGPI-Linked ProteinsHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.